Clinical trial
UDCA for Symptomatic Gallstone Disease
NCT00161083 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00161083 |
|---|---|
| Title | UDCA for Symptomatic Gallstone Disease |
| Official title | Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Dr. Falk Pharma GmbH Industry Dutch Digestive Diseases Foundation ZonMw: The Netherlands Organisation for Health Research and Development Agis Zorgverzekeringen |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cholecystolithiasis |
| Intervention type | Drug |
| Interventions | ursodeoxycholic acid |
| Enrollment | 180 |
| Start date | Nov 1, 2001 |
| Completion | Nov 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 27, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: